• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/16/21 2:20:59 PM ET
    $CSLT
    Managed Health Care
    Health Care
    Get the next $CSLT alert in real time by email
    SC 13G/A 1 d61853dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 8)*

     

     

    CASTLIGHT HEALTH, INC.

    (Name of Issuer)

    Class B Common Stock, $0.0001 par value per share

    (Title of Class of Securities)

    14862Q100

    (CUSIP Number)

    December 31, 2020

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 14862Q100                

     

      1    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      Maverick Capital, Ltd. – 75-2482446

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Texas

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

         5     

      SOLE VOTING POWER

     

      9,077,506 (1)

       6   

      SHARED VOTING POWER

     

      0

       7   

      SOLE DISPOSITIVE POWER

     

      9,077,506 (1)

       8   

      SHARED DISPOSITIVE POWER

     

      0

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      9,077,506 (1)

    10  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      7.2%

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IA

     

    (1)

    Includes 7,216,028 shares of Class A Common Stock held by certain funds managed by Maverick Capital, Ltd. that are convertible at any time into shares of Class B Common Stock as well as options exercisable for 25,000 shares of Class B common stock, 244,154 shares of Class B Common Stock and 45,161 shares of Class B common stock issuable upon the settlement of restricted stock units, held as of December 31, 2020 by Mr. David Singer on behalf of Maverick Capital, Ltd.


    CUSIP No. 14862Q100                

     

      1    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      Maverick Capital Management, LLC – 75-2686461

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Texas

    NUMBER OF

    SHARES

     BENEFICIALLY 

    EACH

    REPORTING

    PERSON

    WITH:

         5     

      SOLE VOTING POWER

     

      9,077,506 (1)

       6   

      SHARED VOTING POWER

     

      0

       7   

      SOLE DISPOSITIVE POWER

     

      9,077,506 (1)

       8   

      SHARED DISPOSITIVE POWER

     

      0

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      9,077,506 (1)

    10  

       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      7.2%

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      HC

     

    (1)

    Includes 7,216,028 shares of Class A Common Stock held by certain funds managed by Maverick Capital, Ltd. that are convertible at any time into shares of Class B Common Stock as well as options exercisable for 25,000 shares of Class B common stock, 244,154 shares of Class B Common Stock and 45,161 shares of Class B common stock issuable upon the settlement of restricted stock units, held as of December 31, 2020 by Mr. David Singer on behalf of Maverick Capital, Ltd.


                        

     

      1    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      Lee S. Ainslie III

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      United States of America

    NUMBER OF

    SHARES

     BENEFICIALLY 

    EACH

    REPORTING

    PERSON

    WITH:

         5     

      SOLE VOTING POWER

     

      9,077,506 (1)

       6   

      SHARED VOTING POWER

     

      0

       7   

      SOLE DISPOSITIVE POWER

     

      9,077,506 (1)

       8   

      SHARED DISPOSITIVE POWER

     

      0

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      9,077,506 (1)

    10  

       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      7.2%

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN

     

    (1)

    Includes 7,216,028 shares of Class A Common Stock held by certain funds managed by Maverick Capital, Ltd. that are convertible at any time into shares of Class B Common Stock as well as options exercisable for 25,000 shares of Class B common stock, 244,154 shares of Class B Common Stock and 45,161 shares of Class B common stock issuable upon the settlement of restricted stock units, held as of December 31, 2020 by Mr. David Singer on behalf of Maverick Capital, Ltd.


    CUSIP No. 14862Q100                

     

      1    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      Andrew H. Warford

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

      (a)  ☐        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      United States of America

    NUMBER OF

    SHARES

     BENEFICIALLY 

    EACH

    REPORTING

    PERSON

    WITH:

         5     

      SOLE VOTING POWER

     

      9,077,506 (1)

       6   

      SHARED VOTING POWER

     

      0

       7   

      SOLE DISPOSITIVE POWER

     

      9,077,506 (1)

       8   

      SHARED DISPOSITIVE POWER

     

      0

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      9,077,506 (1)

    10  

       CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      7.2%

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN

     

    (1)

    Includes 7,216,028 shares of Class A Common Stock held by certain funds managed by Maverick Capital, Ltd. that are convertible at any time into shares of Class B Common Stock as well as options exercisable for 25,000 shares of Class B common stock, 244,154 shares of Class B Common Stock and 45,161 shares of Class B common stock issuable upon the settlement of restricted stock units, held as of December 31, 2020 by Mr. David Singer on behalf of Maverick Capital, Ltd.


                        

     

    Item 1(a).

    Name of Issuer:

    Castlight Health, Inc.

     

    Item 1(b).

    Address of Issuer’s Principal Executive Offices:

    150 Spear Street, Suite 400

    San Francisco, CA 94105

     

    Item 2(a).

    Names of Persons Filing:

    This Schedule 13G (the “Schedule 13G”) is being filed on behalf of each of the following persons (each, a “Reporting Person”):

     

      (i)

    Maverick Capital, Ltd.;

     

      (ii)

    Maverick Capital Management, LLC;

     

      (iii)

    Lee S. Ainslie III (“Mr. Ainslie”); and

     

      (iv)

    Andrew H. Warford (“Mr. Warford”).

    The Schedule 13G relates to Shares (as defined herein) held for the accounts of Maverick Capital, Ltd.’s clients.

     

    Item 2(b).

    Address of Principal Business Office or, if None, Residence:

    The address of the principal business office of each of the Reporting Persons is:

    The address of the principal business office of (i) Maverick Capital, Ltd. and Maverick Capital Management, LLC is 1900 N. Pearl Street, 20th Floor, Dallas, Texas 75201, and (ii) Mr. Ainslie and Mr. Warford is 767 Fifth Avenue, 11th Floor, New York, New York 10153.

     

    Item 2(c).

    Citizenship:

     

      (i)

    Maverick Capital, Ltd. is a Texas limited partnership;

     

      (ii)

    Maverick Capital Management, LLC is a Texas limited liability company;

     

      (iii)

    Mr. Ainslie is a citizen of the United States; and

     

      (iv)

    Mr. Warford is a citizen of the United States.

     

    Item 2(d).

    Title of Class of Securities:

    Class B Common Stock, $0.0001 par value per share (the “Shares”).

     

    Item 2(e).

    CUSIP Number:

    14862Q100


                        

     

    Item 3.

    If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)    ☐    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
    (b)    ☐    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
    (c)    ☐    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
    (d)    ☐    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e)    ☒    An investment advisor in accordance with §240.13d-1(b)(1)(ii)(E).
    (f)    ☐    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
    (g)    ☒    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
    (h)    ☐    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
    (i)    ☐    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
    (j)    ☐    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
    (k)    ☐    Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

    Item 4.

    Ownership.

    Ownership as of December 31, 2020 is incorporated by reference to items (5) – (9) and (11) of the cover page of the Reporting Person.

    Maverick Capital, Ltd. is an investment adviser registered under Section 203 of the Investment Advisers Act of 1940 and, as such, may be deemed to have beneficial ownership of the Shares which are the subject of this filing through the investment discretion it exercises over its clients’ accounts. Maverick Capital Management, LLC is the General Partner of Maverick Capital, Ltd. Mr. Ainslie is the manager of Maverick Capital Management, LLC. Mr. Warford serves as the Chairman of the Stock Committee of Maverick Capital, Ltd.

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

    Not applicable.


    Item 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    Item 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    Item 10.

    Certification.

    By signing below each of the Reporting Persons certifies that, to the best of such person’s knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    SIGNATURE

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Date: February 16, 2021

     

    MAVERICK CAPITAL, LTD.
    By:   Maverick Capital Management, LLC, its General Partner
    By:   Lee S. Ainslie III, Manager
    By:   /s/ Mark Gurevich
     

    Mark Gurevich

    Under Power of Attorney dated March 15, 2018

    MAVERICK CAPITAL MANAGEMENT, LLC
    By:   Lee S. Ainslie III, Manager
    By:   /s/ Mark Gurevich
     

    Mark Gurevich

     

    Under Power of Attorney dated March 15, 2018

    LEE S. AINSLE III
    By:   /s/ Mark Gurevich
      Mark Gurevich
     

    Under Power of Attorney dated March 15, 2018

    ANDREW H. WARFORD
    By:   /s/ Mark Gurevich
      Mark Gurevich
     

    Under Power of Attorney dated March 16, 2018


    EXHIBIT INDEX

     

    A.

    Joint Filing Agreement, dated February 14, 2019, by and among Maverick Capital, Ltd., Maverick Capital Management, LLC, Lee S. Ainslie III and Andrew H. Warford (incorporated by reference to Exhibit 99.A to Schedule 13G, Amendment No. 6 filed by the Reporting Persons with the Securities and Exchange Commission on February 14, 2019).

    Get the next $CSLT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CSLT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CSLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Verhave Judith K. returned 351,516 units of Class B Common Stock to the company, closing all direct ownership in the company

    4 - CASTLIGHT HEALTH, INC. (0001433714) (Issuer)

    2/18/22 2:18:36 PM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form 4: Van Zant Kenny returned 661,794 units of Class B Common Stock to the company, closing all direct ownership in the company

    4 - CASTLIGHT HEALTH, INC. (0001433714) (Issuer)

    2/18/22 2:17:39 PM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form 4: Roberts Bryan E returned 5,660,448 units of Class B Common Stock to the company

    4 - CASTLIGHT HEALTH, INC. (0001433714) (Issuer)

    2/18/22 2:13:57 PM ET
    $CSLT
    Managed Health Care
    Health Care

    $CSLT
    SEC Filings

    View All

    SEC Form 15-12B filed by Castlight Health Inc.

    15-12B - CASTLIGHT HEALTH, INC. (0001433714) (Filer)

    2/28/22 2:02:35 PM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form 25-NSE filed by Castlight Health Inc.

    25-NSE - CASTLIGHT HEALTH, INC. (0001433714) (Subject)

    2/17/22 3:30:16 PM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form S-8 POS filed by Castlight Health Inc.

    S-8 POS - CASTLIGHT HEALTH, INC. (0001433714) (Filer)

    2/17/22 8:55:41 AM ET
    $CSLT
    Managed Health Care
    Health Care

    $CSLT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Castlight Health, Now Part of apree health, Adds Six Digital Health Partners and New Pharmacy Savings Category to its Ecosystem

    New additions bolster the already robust platform, making it even easier for members to identify and access programs best suited to their top health needs SAN FRANCISCO, Sept. 20, 2022 /PRNewswire/ -- Castlight Health, the leading health navigation platform of apree health, today announced six additions to its industry-leading ecosystem, the strongest and most comprehensive with more than 30 fully integrated partners that can be purchased through Castlight, across 20 categories, and the ability to plug in any vendor. These additions—Brightline, Kindbody, RazorMetrics, Rx Savings Solutions, WithMe, and Wondr—include Castlight's first pediatric-focused mental health solution and the launch of

    9/20/22 11:30:00 AM ET
    $CSLT
    Managed Health Care
    Health Care

    Castlight Health Selected to Enable New Capabilities for Blue Cross and Blue Shield of Minnesota

    Castlight's technology and data to power modernized navigation and advocacy solution for health plan members SAN FRANCISCO, June 15, 2022 /PRNewswire/ -- Castlight Health, a leader in connected health navigation, today announced a collaboration with Blue Cross and Blue Shield of Minnesota (Blue Cross) to launch a new health, wellness, and care navigation solution for commercial health plan members, beginning January 1, 2023. The new solution uses Castlight's powerful navigation technology to reduce the overall complexity of healthcare and drive Blue Cross members to more perso

    6/15/22 9:00:00 AM ET
    $CSLT
    Managed Health Care
    Health Care

    Castlight's Workforce Health Index Details the Adverse Health Effects of Delayed Care Due to COVID-19

    Report finds preventive care spending continues to lag but musculoskeletal and behavioral health spending steeply rising SAN FRANCISCO, April 5, 2022 /PRNewswire/ -- Castlight Health, Inc., a leader in connected navigation, today released a new Workforce Health Index, revealing how the COVID-19 pandemic has impacted the way commercially-insured populations across the U.S. utilize their healthcare and wellbeing benefits. The annual Workforce Health Index provides detail on medical spending and benefits utilization from 2018 through 2021 and projected spending for 2022, as well as a state-by-state dataset demonstrating regional variation in medical spending over this five-year period.

    4/5/22 9:00:00 AM ET
    $CSLT
    Managed Health Care
    Health Care

    $CSLT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity reiterated coverage on Castlight Health with a new price target

    Canaccord Genuity reiterated coverage of Castlight Health with a rating of Hold and set a new price target of $2.00 from $1.00 previously

    2/11/21 11:30:07 AM ET
    $CSLT
    Managed Health Care
    Health Care

    $CSLT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Castlight Health Inc. (Amendment)

    SC 13G/A - CASTLIGHT HEALTH, INC. (0001433714) (Subject)

    2/14/22 3:29:59 PM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form SC 13G/A filed by Castlight Health Inc. (Amendment)

    SC 13G/A - CASTLIGHT HEALTH, INC. (0001433714) (Subject)

    2/9/22 9:07:15 AM ET
    $CSLT
    Managed Health Care
    Health Care

    SEC Form SC 13G filed by Castlight Health Inc.

    SC 13G - CASTLIGHT HEALTH, INC. (0001433714) (Subject)

    2/4/22 4:12:10 PM ET
    $CSLT
    Managed Health Care
    Health Care

    $CSLT
    Financials

    Live finance-specific insights

    View All

    Castlight Health Announces Third Quarter 2021 Results

    SAN FRANCISCO, Nov. 2, 2021 /PRNewswire/ -- Castlight Health, Inc. (NYSE:CSLT), a leading health navigation platform provider, today announced results for its third quarter ended September 30, 2021. "We delivered a solid third quarter reflecting continued progress across both our employer and health plan businesses," said Maeve O'Meara, chief executive officer of Castlight Health. "This quarter our team produced our highest direct-to-employer bookings in over three years, which led to our third straight quarter of sequential ARR growth, and our health plan pipeline grew substa

    11/2/21 4:05:00 PM ET
    $CSLT
    Managed Health Care
    Health Care

    Castlight Health to Announce Third Quarter 2021 Results

    SAN FRANCISCO, Oct. 19, 2021 /PRNewswire/ -- Castlight Health, Inc. (NYSE:CSLT), a leader in healthcare navigation, will release its third quarter 2021 financial results on Tuesday, November 2, 2021, after the market close. At 5:00 p.m. Eastern Time, senior management will host a conference call to review the company's financial performance. The live conference call will be available at (833) 238-7953. Please dial in at least five minutes before the scheduled start time to register. The call replay will be available for one week, starting at 8:00 p.m. ET on November 2, 2021

    10/19/21 8:30:00 AM ET
    $CSLT
    Managed Health Care
    Health Care

    Castlight Health Announces Second Quarter 2021 Results

    SAN FRANCISCO, Aug. 3, 2021 /PRNewswire/ -- Castlight Health, Inc. (NYSE:CSLT), a leading health navigation platform provider, today announced results for its second quarter ended June 30, 2021. "We had a strong second quarter, achieving the top-end of our revenue guidance and generating our fifth straight quarter of non-GAAP profitability and positive cash flow," said Maeve O'Meara, chief executive officer of Castlight Health. "We were pleased with pipeline progress, as our late-stage pipeline for the quarter is the largest in four years, we reported a second low churn quarte

    8/3/21 4:05:00 PM ET
    $CSLT
    Managed Health Care
    Health Care